Researchers have developed a new blood test that detects early stage ovarian cancer and may determine whether a pelvic mass is benign or cancerous with 91 per cent accuracy, a rate better than existing tests.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.